# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
1 | 08-06-2025 | 06-30-2025 | 10-Q | |
2 | 05-08-2025 | 03-31-2025 | 10-Q | |
3 | 03-24-2025 | 12-31-2024 | 10-K | |
4 | 11-12-2024 | 09-30-2024 | 10-Q | |
5 | 08-29-2024 | 06-30-2024 | 10-Q |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Biotech stocks have trailed the broader market this year, but more names are starting to show strength as the rally expands and...
Shares of Artiva Biotherapeutics, Inc. are rising Friday after the San Diego-based biotech company shared a milestone regulator...
Wedbush analyst Martin Fan maintains Artiva Biotherapeutics (NASDAQ:ARTV) with a Outperform and raises the price target fro...
CSX: 3% | CSX shares are trading higher after the company reported better-than-expected Q3 financial results. ARTV: 144% | Arti...